Leading Exporter of Oncology Biosimilars to South Africa & Worldwide Healthcare Markets
Cordium Pharmaceuticals Pvt Ltd is a trusted India-based pharmaceutical exporter specializing in high-quality biosimilar oncology injections, including Rituximab Biosimilar 100mg and 500mg vials. We supply to hospitals, oncology centers, clinics, retail pharmacies, government procurement agencies, and verified personal import buyers across global regulated and semi-regulated markets.
Our strong export network ensures reliable availability of Rituximab Biosimilar injections across South Africa – Gauteng, Western Cape, KwaZulu-Natal, Eastern Cape, and Free State, with secure cold-chain logistics and documentation support.
Rituximab Biosimilar Injection Overview (CD20 Targeted Therapy)
Rituximab Biosimilar is a monoclonal antibody therapy designed to target CD20 antigen on B-lymphocytes, making it highly effective in treating several hematological cancers and autoimmune disorders.
As a biosimilar product, it provides a clinically equivalent alternative to originator biologics, helping healthcare systems improve treatment accessibility while reducing overall therapy costs.
Product Strengths Available for Export
- Rituximab Biosimilar Injection 100mg
- Rituximab Biosimilar Injection 500mg
Both presentations are widely used in hospital protocols for oncology and immunology treatment regimens.
Therapeutic Applications & Clinical Use
Rituximab Biosimilar is commonly indicated in:
- Non-Hodgkin’s Lymphoma (NHL) treatment protocols
- Chronic Lymphocytic Leukemia (CLL) management
- Rheumatoid Arthritis (moderate to severe cases)
- Granulomatosis with Polyangiitis (GPA)
- Microscopic Polyangiitis (MPA)
- B-cell mediated autoimmune disorders
It is widely included in global oncology treatment guidelines and immunotherapy combinations.
Administration Method & Clinical Guidelines
- Administered via intravenous infusion only (IV use)
- Must be given in hospital or clinical oncology settings
- Dosage is determined based on medical condition and protocol
- Requires trained healthcare supervision due to infusion sensitivity
- Premedication may be used to minimize infusion reactions
⚠️ Prescription-based biologic therapy – not for self-administration.
Key Advantages of Our Rituximab Biosimilar Supply
- High-quality biosimilar manufactured under strict GMP conditions
- Cost-efficient alternative for long-term cancer therapy programs
- Consistent batch quality with regulatory documentation support
- Export-ready cold-chain packaging (2°C–8°C compliance)
- Secure global shipping with tracking and compliance paperwork
- Suitable for institutional procurement and authorized import channels
Global Export Destinations
Cordium Pharmaceuticals Pvt Ltd supplies Rituximab Biosimilar injections to:
🌍 South Africa
- Gauteng
- Western Cape
- KwaZulu-Natal
- Eastern Cape
- Free State
🌍 Other major markets:
- Middle East
- Africa
- Asia
- Europe
- Latin America
We support bulk hospital orders, pharmacy distribution networks, tender supplies, and verified personal import shipments.
Storage & Transportation Requirements
- Maintain temperature between 2°C and 8°C
- Do not freeze under any condition
- Protect from direct sunlight exposure
- Ensure validated cold-chain logistics during transit
- Store only in medical refrigeration systems
Why Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is recognized for:
✔ Strong expertise in oncology biosimilars export
✔ Reliable international pharmaceutical supply chain
✔ Competitive global pricing model
✔ Documentation support for cross-border shipments
✔ Strict adherence to pharmaceutical compliance standards
✔ Fast response for international enquiries and procurement needs
Clinical Importance in Modern Oncology
Rituximab Biosimilar plays a critical role in:
- Targeted cancer therapy (CD20-directed treatment)
- Combination chemotherapy regimens (e.g., R-CHOP protocols)
- Autoimmune disease immunomodulation
- Reducing relapse rates in B-cell malignancies
- Expanding access to biologic treatments in developing healthcare systems
Contact for Orders & Business Enquiry
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
🌐 Cordium Pharmaceuticals Pvt Ltd – International Export Division (India)